← Scroll for more →
Lantheus Holdings, Inc. (LNTH)
In Vitro & In Vivo Diagnostic Substances
Latest Price
$99.53
TTM P/E
23.81
Normalized P/E
31.25
Div Yield
--
Book Value
20.15
P/B Ratio
4.94
Valuation metrics
adjust assumptions →EPS: $3.41
Book value / share: $16.87
Formula: √(22.5 × EPS × BVPS)
Graham Number
$35.98
64% downside
Norm. op. income: $52M (median of 7yr)
Tax rate: 26%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$2.71
97% downside
Base FCF: $260M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$65.38
34% downside
EPS: $3.41
Target P/E: 31×
Formula: EPS × P/E
P/E Fair Value
$105.71
+6% upside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.40M | $931.0M | 12.87% | +214.4K | 2026-06-30 |
| Farallon Capital Management, L.L.C. | 5.58M | $619.0M | 8.56% | -- | 2026-06-30 |
| Jupiter Topco LLC | 5.19M | $575.0M | 7.95% | -- | 2026-06-30 |
| FMR LLC | 3.88M | $430.0M | 5.94% | -746.5K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.24M | $359.0M | 4.96% | +64.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.93M | $325.0M | 4.49% | +17.9K | 2026-06-30 |
| American Century Companies Inc | 2.82M | $312.0M | 4.32% | +1.04M | 2026-06-30 |
| State Street Corp | 2.50M | $277.0M | 3.83% | +70.9K | 2026-06-30 |
| Price T Rowe Associates Inc | 1.90M | $211.0M | 2.92% | +983.6K | 2026-06-30 |
| Geode Capital Management, LLC | 1.84M | $204.0M | 2.82% | +75.4K | 2026-06-30 |